Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Upreti

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
European Journal of Medicinal Chemistry|October 17, 2003
New styryl sulfones as anticancer agentsManohar Sharma Vedula, Aravind Babu Pulipaka, Chandrasekhar Venna, et al.
Clinical Pharmacology and Therapeutics|May 16, 2024
Dose Optimization in Oncology Drug Development: An International Consortium for Innovation and Quality in Pharmaceutical Development White PaperDivya Samineni, Karthik Venkatakrishnan, Ahmed A Othman, et al.
Clinical Pharmacology and Therapeutics|May 15, 2021
Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot ProgramGerald R Galluppi, Satjit Brar, Luzelena Caro, et al.
The AAPS Journal|July 31, 2023
PK/PD and Bioanalytical Considerations of AAV-Based Gene Therapies: an IQ Consortium Industry Position PaperUma Kavita, Kefeng Sun, Manuela Braun, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
European Journal of Medicinal Chemistry|October 17, 2003
New styryl sulfones as anticancer agentsManohar Sharma Vedula, Aravind Babu Pulipaka, Chandrasekhar Venna, et al.
Clinical Pharmacology and Therapeutics|May 16, 2024
Dose Optimization in Oncology Drug Development: An International Consortium for Innovation and Quality in Pharmaceutical Development White PaperDivya Samineni, Karthik Venkatakrishnan, Ahmed A Othman, et al.
Clinical Pharmacology and Therapeutics|May 15, 2021
Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot ProgramGerald R Galluppi, Satjit Brar, Luzelena Caro, et al.
The AAPS Journal|July 31, 2023
PK/PD and Bioanalytical Considerations of AAV-Based Gene Therapies: an IQ Consortium Industry Position PaperUma Kavita, Kefeng Sun, Manuela Braun, et al.
Pageof 7